Doctor Sam Zeraatian-Nejad Davani, Assistant Professor of Cardiovascular Surgery Department of General Surgery, School of Medicine Hazrat-e Rasool General Hospital affiliated with Iran University of Medical Sciences, explained the procedure in a report published by ISNA news agency on Monday.
Davani said that while organ transplants after cardiac death or brain death have been performed for years in Iran, organ transplants from patients who were confirmed dead was carried out for the first time in Iran and the Middle East in association with a knowledge-based company.
Vital organs including kidney, liver, pancreas, intestines, and heart valve were harvested from three dead donors for transplants, Davani said.
While after death both the quantity and quality of organs available for transplant will be adversely affected due to an inflammatory response, as Davani said by using a haemoperfusion cartridge, which helps to remove pro-inflammatory cytokines in cytokine storm and other cellular inflammatory markers the donors organs remain viable for transplant.
The procedure is approved by the Middle East Society for Organ Transplantation, he added.
A research program is designed to introduce the procedure using a haemoperfusion cartridge (HA380) to other universities of medical sciences in the country to save the lives of people who are on transplant waitlists, he added.
According to the Iran University of Medical Sciences public relations over the past five years, some 700 transplant surgeries were performed in the university’s transplant centers.